Analysts expect some margin expansion over the next few years while sales growth is anticipated to normalize back down to ~5% levels in the coming years. We recently trimmed this position in our growth model portfolio as it has performed well since we added it, and its valuations are on the high end of its historical averages, with a forward P/E of 21.2X and a forward sales multiple of 1.7X. Its debt levels have been expanding over the past several years, and its net debt to EBITDA is somewhat high at 2.6X. Although, we continue to like the company and feel that it can perform well over the next five years.
5i Research Answer: